Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.

JAMA Neurol.

Dean DC 3rd, Hurley SA, Kecskemeti SR, O'Grady JP, Canda C, Davenport-Sis NJ, Carlsson CM, Zetterberg H, Blennow K, Asthana S, Sager MA, Johnson SC, Alexander AL, Bendlin BB

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsAlzheimer’s DiseaseMultiple Sclerosis

Alzheimer disease pathology and the cerebrospinal fluid proteome

Alzheimers Res Ther.

Dayon L, Núñez Galindo A, Wojcik J, Cominetti O, Corthésy J, Oikonomidi A, Henry H, Kussmann M, Migliavacca E, Severin I, Bowman GL, Popp J

doi: 10.1186/s13195-018-0397-4.

Aging and Cognitive Functions

Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease

Brain.

Shinohara M, Koga S, Konno T, Nix J, Shinohara M, Aoki N, Das P, Parisi JE, Petersen RC, Rosenberry TL, Dickson DW, Bu G

doi: 10.1093/brain/awx284.

Aging and Cognitive FunctionsAlzheimer’s Disease

Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

JAMA Neurol.

Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsAlzheimer’s Disease

An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease

Neurology.

Brickman AM, Tosto G, Gutierrez J, Andrews H, Gu Y, Narkhede A, Rizvi B, Guzman V, Manly JJ, Vonsattel JP, Schupf N, Mayeux R

doi: 10.1212/

Aging and Cognitive Functions

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Nature

Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K

doi: 10.1038/nature25456.

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Linking Amyloid-β and Tau Deposition in Alzheimer Disease

JAMA Neurol.

Vemuri P, Schöll M

doi: 10.1001/

Alzheimer’s Disease

Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease

JAMA Neurol.

Yu L, Petyuk VA, Tasaki S, Boyle PA, Gaiteri C, Schneider JA, De Jager PL, Bennett DA

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsAlzheimer’s Disease

Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals

JAMA Neurol.

Vemuri P, Knopman DS, Lesnick TG, Przybelski SA, Mielke MM, Graff-Radford J, Murray ME, Roberts RO, Vassilaki M, Lowe VJ, Machulda MM, Jones DT, Petersen RC, Jack CR Jr

doi: 10.1001/

Related content

Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.

Alzheimer disease pathology and the cerebrospinal fluid proteome

Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease

Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Linking Amyloid-β and Tau Deposition in Alzheimer Disease

Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease

Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals